Cryptocurrency Analysis and News Portal
Following the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0.86% higher on Thursday gained more than 7.33% in the pre-market.American vaccine development company Novavax Inc (NASDAQ: NVAX) has revealed that it has commenced its late-large COVID-19 vaccine trials in the United Kingdom stirring a rise
Read More
AstraZeneca has received partial immunity from the EU in a vaccine deal. The EU has already paid €336 million at €2.5 per dose.AstraZeneca Plc (LON: AZN) has received partial immunity from the European government over its potential vaccine deal. Compared to French pharmaceutical company Sanofi SA (NASDAQ: SNY), AstraZeneca’s vaccine
Read More
Moderna COVID-19 vaccine candidate dubbed mRNA-1273 has entered its late-stage trials. The company noted that as of Wednesday, September 16, 2020, about 25,296 participants have been enrolled.The CEO of biotechnology company Moderna Inc (NASDAQ: MRNA) Stephane Bancel has disclosed the company will know whether its COVID-19 vaccine candidate will be
Read More
In partnership with U.K.’s Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK’s Medicines Health Regulatory Authority. After pausing its work on the coronavirus vaccine citing safety concerns last week, pharmaceutical giant AstraZeneca plc
Read More
With the company’s ongoing late-stage clinical trials and its impressive H1 performance results, AstraZeneca (AZN) stock jumped in the pre-market.Foremost leader in the search for COVID-19 vaccine AstraZeneca Plc (NYSE: AZN) has posted its H1 performance report. The company’s released result shows an impressive earning spiked by increasing demand for
Read More
The U.S. Government has signed a $1.95 billion deal with Pfizer and BioNTech for their COVID-19 vaccine. The prices PFE and BNTX stocks are moving higher.The United States has agreed to pay Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) $1.95 billion for a safe and effective coronavirus vaccine.
Read More
Data from AstraZeneca’s clinical trials of its COVID-19 vaccine candidate AZD1222 shows promising results but AZN share price has refused to be positively impacted.The world is still ecstatic with the hope of getting a vaccine that can guarantee a lasting and viable solution to the COVID-19 pandemic. As several pharmaceutical
Read More
Her Majesty’s Government has ordered 90 million doses of Pfizer COVID-19 vaccine candidate which became a stimulus for the PFE stock price rise. Moreover, the UK is going to be a worldwide leader in the search for a working vaccine.Pfizer Inc (NYSE: PFE) stock price has gone up 3.34% in
Read More
Following the company’s announcement about the success of its COVID-19 vaccine, Synairgen stock has increased significantly. Now it is nearly 470% up.British pharmaceutical company Synairgen Plc (LON: SNG) that is taking part in the COVID-19 vaccine race has announced positive results for the trial of its vaccine candidate. According to
Read More
Moderna (MRNA) stock price is rising. The rally is fueled by the company’s announcement that its COVID-19 vaccine candidate produced neutralizing antibodies in all 45 participants.Moderna Inc (NASDAQ: MRNA) stock rose by 15.88% to $92.72 to retest the previous ATH. Investors in the company had something concrete to hold on
Read More